ProMIS Neurosciences to Present at H.C. Wainwright Conference
ProMIS Neurosciences Inc. (Nasdaq: PMN) is set to make waves at the H.C. Wainwright 25th Annual Global Investment Conference. The company's CEO, Dr. Gail Farfel, and CMO, Dr. Larry Altstiel, will present on September 12, 2023, in New York, NY, at 4:30 p.m. ET.
ProMIS Neurosciences, a leader in antibody therapeutics for neurodegenerative diseases, has been making strides globally. Before their appearance at the conference, CEO Dr. Farfel and CMO Dr. Altstiel have been instrumental in forging international partnerships and research collaborations. The company's focus lies in treating conditions such as Alzheimer's, ALS, and MSA. Their presentation at the H.C. Wainwright conference is eagerly anticipated by investors and industry professionals alike.
Dr. Farfel and Dr. Altstiel's presentation at the H.C. Wainwright conference promises to provide valuable insights into ProMIS Neurosciences' ongoing work in the field of neurodegenerative diseases. The company's global presence and commitment to research make it a key player in the sector.
Read also:
- Hospital's Enhancement of Outpatient Services Alleviates Emergency Department Strain
- Increased Chikungunya infections in UK travelers prompt mosquito bite caution
- Kazakhstan's Deputy Prime Minister holds discussions on the prevailing circumstances in Almaty
- In the state, Kaiser Permanente boasts the top-ranked health insurance program
